Shares of Viking Therapeutics ( NASDAQ:VKTX ) soared more than 114% on Tuesday after the company's experimental weight loss drug showed promising initial results in a mid-stage trial.
Viking Therapeutics ( NASDAQ:VKTX ) is one of several small obesity drugmakers hoping to enter the budding weight loss drug industry, which analysts say could grow into a $100...
Hello, Trading View,
This is one of those stocks that have cought the attention of investors.com and so you will usually see a rise in the value of these stocks if it is on the front page of there web site.
It usually just continues up the trend line until you reach that upper resistance line. That is where I will be selling it to practice risk management.
IMO...